Published online before print September 6, 2007

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2007.070406v1 171/5/1538    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Vogel, C. F.A. Articles by Matsumura, F. Search for Related Content PubMed PubMed Citation Articles by Vogel, C. F.A. Articles by Matsumura, F.

Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.070406

Accepted for publication June 29, 2007.

Article

Pathogenesis of Aryl Hydrocarbon Receptor-Mediated Development of Lymphoma Is Associated with Increased Cyclooxygenase-2 Expression

Christoph F.A. Vogel^*@, Wen Li^*, Eric Sciullo^*, John Newman, Bruce Hammock, J. Rachel Reader, Joseph Tuscano^¶, and Fumio Matsumura^*

From the Departments of Environmental Toxicology,* and Entomology, the Nutrition Department, and the Comparative Pathology Laboratory, School of Veterinary Medicine, University of California, Davis, Davis; and the Department of Internal Medicine,^¶ Division of Hematology and Oncology, Cancer Center, University of California, Sacramento, California

^@ To whom correspondence should be addressed. E-mail: cfvogel{at}ucdavis.edu.

	Abstract

Epidemiological studies indicate that exposure to environmental pollutants such as pesticides and dioxins leads to the pathogenesis of lymphoma and leukemia. Here, we show that activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in loss of the programmed cell death (apoptosis) response in three different lymphoma cell lines, which plays a key role in the development of cancer, especially lymphoma and leukemia. The AhR-mediated inhibition of apoptosis in vitro was associated with a clear increase of cyclooxygenase-2 (COX-2) and deregulation of genes of the B-cell lymphoma-2 (Bcl-2) family involved in apoptosis including Bcl-xl and Mcl-1 in several lymphoma cell lines. Treatment with the COX-2 inhibitor NS-398 and the AhR antagonist 3'-methoxy-4'-nitroflavone abolished the TCDD-induced resistance of apoptosis in vitro. Furthermore, using micropositron emission tomography imaging, in vivo findings demonstrated that exposure to TCDD promotes the development of lymphoma in superficial lymph nodes of C57BL/10J mice, which was associated with a marked increase of COX-2 expression in the affected lymph nodes. The results indicate that AhR activation and COX-2 overexpression likely represent a mechanism of resistance to apoptosis in lymphoma cell lines that might be relevant for the development of lymphoma in vivo.